Democrats’ next big bill could include drug price negotiations and other industry curbs. Pharma may not be able to fight it off this time.
Related posts:
China says it is ‘shocked’ by WHO plan for Covid origins study
Government leaders to their workers: Get vaccinated or get tested
Pfizer, BioNTech say Covid-19 shot for kids is safe and provokes strong immune response
Supreme Court sets Dec. 1 for arguments in challenge to Roe v. Wade
Pfizer’s Covid-19 pill cut risk of hospitalization and death by 89 percent, final results show
Why — and how — we created the State Pandemic Scorecard
HHS forecast shows Omicron stretching U.S. Covid testing supply
Fauci worried about increased hospitalizations but hopeful about schools
Bid to fund national patient IDs revives privacy fight
Beijing to offer Olympic tickets to ‘selected’ spectators amid pandemic
How many health care workers are vaccinated? It’s anyone’s guess
POLITICO-Harvard poll: Big domestic spending bills seen as stoking inflation
